1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	Lipid	_	_	NN	_	_	_	_	_
2	oxidation	_	_	NN	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	one	_	_	CD	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	major	_	_	JJ	_	_	_	_	_
8	causes	_	_	NNS	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	food	_	_	NN	_	_	_	_	_
11	deterioration	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	leading	_	_	VBG	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	loss	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	nutrients	_	_	NNS	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	bioactives	_	_	NNS	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	off	_	_	IN	_	_	_	_	_
23	flavors	_	_	NNS	_	_	_	_	_
24	development	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	could	_	_	MD	_	_	_	_	_
28	also	_	_	RB	_	_	_	_	_
29	form	_	_	VB	_	_	_	_	_
30	potentially	_	_	RB	_	_	_	_	_
31	toxic	_	_	JJ	_	_	_	_	_
32	compounds	_	_	NNS	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	use	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	synthetic	_	_	JJ	_	_	_	_	_
5	antioxidants	_	_	NNS	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	such	_	_	JJ	_	_	_	_	_
8	as	_	_	IN	_	_	_	_	_
9	butylated	_	_	JJ	_	_	_	_	_
10	hydroxytoluene	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	butylated	_	_	VBN	_	_	_	_	_
13	hydroxyanisole	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	or	_	_	CC	_	_	_	_	_
16	n-propyl	_	_	NN	_	_	_	_	_
17	gallate	_	_	NN	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	delay	_	_	VB	_	_	_	_	_
20	lipid	_	_	JJ	_	_	_	_	_
21	oxidation	_	_	NN	_	_	_	_	_
22	is	_	_	VBZ	_	_	_	_	_
23	currently	_	_	RB	_	_	_	_	_
24	questioned	_	_	VBN	_	_	_	_	_
25	due	_	_	JJ	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	their	_	_	PRP$	_	_	_	_	_
28	possible	_	_	JJ	_	_	_	_	_
29	harmful	_	_	JJ	_	_	_	_	_
30	effects	_	_	NNS	_	_	_	_	_
31	on	_	_	IN	_	_	_	_	_
32	human	_	_	JJ	_	_	_	_	_
33	health	_	_	NN	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	and	_	_	CC	_	_	_	_	_
36	the	_	_	DT	_	_	_	_	_
37	use	_	_	NN	_	_	_	_	_
38	of	_	_	IN	_	_	_	_	_
39	natural	_	_	JJ	_	_	_	_	_
40	antioxidants	_	_	NNS	_	_	_	_	_
41	is	_	_	VBZ	_	_	_	_	_
42	of	_	_	IN	_	_	_	_	_
43	growing	_	_	VBG	_	_	_	_	_
44	interest	_	_	NN	_	_	_	_	_
45	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	recent	_	_	JJ	_	_	_	_	_
3	years	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	flavonoids	_	_	NNS	_	_	_	_	_
6	have	_	_	VBP	_	_	_	_	_
7	been	_	_	VBN	_	_	_	_	_
8	used	_	_	VBN	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	improve	_	_	VB	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	oxidative	_	_	JJ	_	_	_	_	_
13	stability	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	foods	_	_	NNS	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	main	_	_	JJ	_	_	_	_	_
3	mechanisms	_	_	NNS	_	_	_	_	_
4	by	_	_	IN	_	_	_	_	_
5	which	_	_	WDT	_	_	_	_	_
6	flavonoids	_	_	NNS	_	_	_	_	_
7	act	_	_	VBP	_	_	_	_	_
8	against	_	_	IN	_	_	_	_	_
9	lipid	_	_	JJ	_	_	_	_	_
10	oxidation	_	_	NN	_	_	_	_	_
11	involve	_	_	VBP	_	_	_	_	_
12	transferring	_	_	VBG	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	hydrogen	_	_	NN	_	_	_	_	_
15	atom	_	_	NN	_	_	_	_	_
16	or	_	_	CC	_	_	_	_	_
17	electrons	_	_	NNS	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	a	_	_	DT	_	_	_	_	_
20	peroxyl	_	_	NN	_	_	_	_	_
21	radical	_	_	JJ	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	metal	_	_	NN	_	_	_	_	_
24	chelation	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	Free	_	_	JJ	_	_	_	_	_
2	flavonoids	_	_	NNS	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	mainly	_	_	RB	_	_	_	_	_
5	quercetin	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	myricetin	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	morin	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	(	_	_	-LRB-	_	_	_	_	_
12	+)catechin	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	(	_	_	-LRB-	_	_	_	_	_
15	−)epigallocatechin	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	(	_	_	-LRB-	_	_	_	_	_
18	−)epicatechin	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	kaempferol	_	_	NN	_	_	_	_	_
22	have	_	_	VBP	_	_	_	_	_
23	been	_	_	VBN	_	_	_	_	_
24	incorporated	_	_	VBN	_	_	_	_	_
25	in	_	_	IN	_	_	_	_	_
26	different	_	_	JJ	_	_	_	_	_
27	lipid	_	_	JJ	_	_	_	_	_
28	systems	_	_	NNS	_	_	_	_	_
29	with	_	_	IN	_	_	_	_	_
30	varying	_	_	VBG	_	_	_	_	_
31	degrees	_	_	NNS	_	_	_	_	_
32	of	_	_	IN	_	_	_	_	_
33	success	_	_	NN	_	_	_	_	_
34	in	_	_	IN	_	_	_	_	_
35	terms	_	_	NNS	_	_	_	_	_
36	of	_	_	IN	_	_	_	_	_
37	oxidative	_	_	JJ	_	_	_	_	_
38	stability	_	_	NN	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	incorporation	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	free	_	_	JJ	_	_	_	_	_
5	flavonoids	_	_	NNS	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	lipid	_	_	NN	_	_	_	_	_
8	systems	_	_	NNS	_	_	_	_	_
9	may	_	_	MD	_	_	_	_	_
10	have	_	_	VB	_	_	_	_	_
11	some	_	_	DT	_	_	_	_	_
12	drawbacks	_	_	NNS	_	_	_	_	_
13	since	_	_	IN	_	_	_	_	_
14	these	_	_	DT	_	_	_	_	_
15	phenolic	_	_	JJ	_	_	_	_	_
16	compounds	_	_	NNS	_	_	_	_	_
17	have	_	_	VBP	_	_	_	_	_
18	limited	_	_	VBN	_	_	_	_	_
19	solubility	_	_	NN	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	stability	_	_	NN	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	together	_	_	RB	_	_	_	_	_
24	with	_	_	IN	_	_	_	_	_
25	unpleasant	_	_	JJ	_	_	_	_	_
26	flavors	_	_	NNS	_	_	_	_	_
27	in	_	_	IN	_	_	_	_	_
28	some	_	_	DT	_	_	_	_	_
29	cases	_	_	NNS	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	Encapsulation	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	flavonoids	_	_	NNS	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	technology	_	_	NN	_	_	_	_	_
7	which	_	_	WDT	_	_	_	_	_
8	could	_	_	MD	_	_	_	_	_
9	enhance	_	_	VB	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	stability	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	flavonoids	_	_	NNS	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	Among	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	encapsulation	_	_	NN	_	_	_	_	_
4	methods	_	_	NNS	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	spray-drying	_	_	NN	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	most	_	_	RBS	_	_	_	_	_
10	widely	_	_	RB	_	_	_	_	_
11	used	_	_	VBN	_	_	_	_	_
12	for	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	encapsulation	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	bioactive	_	_	JJ	_	_	_	_	_
17	compounds	_	_	NNS	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	food	_	_	NN	_	_	_	_	_
21	industry	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Inulin	_	_	NNP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	linear	_	_	JJ	_	_	_	_	_
5	fructo-oligosaccharide	_	_	NN	_	_	_	_	_
6	composed	_	_	VBN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	fructosyl	_	_	NN	_	_	_	_	_
9	units	_	_	NNS	_	_	_	_	_
10	(	_	_	-LRB-	_	_	_	_	_
11	β	_	_	NN	_	_	_	_	_
12	(	_	_	-LRB-	_	_	_	_	_
13	2→1	_	_	CD	_	_	_	_	_
14	)	_	_	-RRB-	_	_	_	_	_
15	linkage	_	_	NN	_	_	_	_	_
16	)	_	_	-RRB-	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	usually	_	_	RB	_	_	_	_	_
19	contains	_	_	VBZ	_	_	_	_	_
20	one	_	_	CD	_	_	_	_	_
21	terminal	_	_	JJ	_	_	_	_	_
22	glucose	_	_	NN	_	_	_	_	_
23	moiety	_	_	NN	_	_	_	_	_
24	per	_	_	IN	_	_	_	_	_
25	molecule	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_
27	β-linkage	_	_	NN	_	_	_	_	_
28	makes	_	_	VBZ	_	_	_	_	_
29	inulin	_	_	NN	_	_	_	_	_
30	resistant	_	_	JJ	_	_	_	_	_
31	to	_	_	TO	_	_	_	_	_
32	hydrolysis	_	_	NN	_	_	_	_	_
33	by	_	_	IN	_	_	_	_	_
34	human	_	_	JJ	_	_	_	_	_
35	gastrointestinal	_	_	JJ	_	_	_	_	_
36	enzymes	_	_	NNS	_	_	_	_	_
37	and	_	_	CC	_	_	_	_	_
38	it	_	_	PRP	_	_	_	_	_
39	is	_	_	VBZ	_	_	_	_	_
40	classified	_	_	VBN	_	_	_	_	_
41	as	_	_	IN	_	_	_	_	_
42	colonic	_	_	JJ	_	_	_	_	_
43	delivery	_	_	NN	_	_	_	_	_
44	biopolymer	_	_	NN	_	_	_	_	_
45	.	_	_	.	_	_	_	_	_


1	Although	_	_	IN	_	_	_	_	_
2	inulin	_	_	NN	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	moderately	_	_	RB	_	_	_	_	_
5	water	_	_	NN	_	_	_	_	_
6	soluble	_	_	JJ	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	it	_	_	PRP	_	_	_	_	_
9	is	_	_	VBZ	_	_	_	_	_
10	used	_	_	VBN	_	_	_	_	_
11	as	_	_	IN	_	_	_	_	_
12	an	_	_	DT	_	_	_	_	_
13	encapsulating	_	_	VBG	_	_	_	_	_
14	agent	_	_	NN	_	_	_	_	_
15	by	_	_	IN	_	_	_	_	_
16	spray	_	_	NN	_	_	_	_	_
17	drying	_	_	VBG	_	_	_	_	_
18	due	_	_	JJ	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	low	_	_	JJ	_	_	_	_	_
21	viscosity	_	_	NN	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	colorless	_	_	JJ	_	_	_	_	_
24	solutions	_	_	NNS	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	there	_	_	EX	_	_	_	_	_
4	are	_	_	VBP	_	_	_	_	_
5	few	_	_	JJ	_	_	_	_	_
6	studies	_	_	NNS	_	_	_	_	_
7	focused	_	_	VBN	_	_	_	_	_
8	on	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	effect	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	incorporation	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	microencapsulated	_	_	JJ	_	_	_	_	_
16	flavonoids	_	_	NNS	_	_	_	_	_
17	on	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	oxidative	_	_	JJ	_	_	_	_	_
20	stability	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	lipid	_	_	NN	_	_	_	_	_
23	systems	_	_	NNS	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	previous	_	_	JJ	_	_	_	_	_
3	studies	_	_	NNS	_	_	_	_	_
4	undertaken	_	_	VBN	_	_	_	_	_
5	by	_	_	IN	_	_	_	_	_
6	our	_	_	PRP$	_	_	_	_	_
7	research	_	_	NN	_	_	_	_	_
8	group	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	flavonoids	_	_	NNS	_	_	_	_	_
11	were	_	_	VBD	_	_	_	_	_
12	microencapsulated	_	_	VBN	_	_	_	_	_
13	with	_	_	IN	_	_	_	_	_
14	inulin	_	_	NN	_	_	_	_	_
15	(	_	_	-LRB-	_	_	_	_	_
16	lipid-insoluble	_	_	JJ	_	_	_	_	_
17	polymer	_	_	NN	_	_	_	_	_
18	)	_	_	-RRB-	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	where	_	_	WRB	_	_	_	_	_
21	channelizing	_	_	VBG	_	_	_	_	_
22	agents	_	_	NNS	_	_	_	_	_
23	(	_	_	-LRB-	_	_	_	_	_
24	lipid-soluble	_	_	JJ	_	_	_	_	_
25	polymer	_	_	NN	_	_	_	_	_
26	)	_	_	-RRB-	_	_	_	_	_
27	were	_	_	VBD	_	_	_	_	_
28	incorporated	_	_	VBN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	microparticles	_	_	NNS	_	_	_	_	_
3	were	_	_	VBD	_	_	_	_	_
4	able	_	_	JJ	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	release	_	_	VB	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	encapsulated	_	_	VBN	_	_	_	_	_
9	flavonoids	_	_	NNS	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	improve	_	_	VB	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	oxidative	_	_	JJ	_	_	_	_	_
14	stability	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	methyl	_	_	NN	_	_	_	_	_
17	linoleate	_	_	NN	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	vegetable	_	_	NN	_	_	_	_	_
20	oils	_	_	NNS	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	which	_	_	WDT	_	_	_	_	_
23	was	_	_	VBD	_	_	_	_	_
24	attributed	_	_	VBN	_	_	_	_	_
25	to	_	_	TO	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	formation	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	channels	_	_	NNS	_	_	_	_	_
30	inside	_	_	IN	_	_	_	_	_
31	the	_	_	DT	_	_	_	_	_
32	microparticles	_	_	NNS	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	favoring	_	_	VBG	_	_	_	_	_
35	the	_	_	DT	_	_	_	_	_
36	diffusion	_	_	NN	_	_	_	_	_
37	of	_	_	IN	_	_	_	_	_
38	flavonoids	_	_	NNS	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	general	_	_	JJ	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	powders	_	_	NNS	_	_	_	_	_
5	obtained	_	_	VBN	_	_	_	_	_
6	by	_	_	IN	_	_	_	_	_
7	spray-drying	_	_	NN	_	_	_	_	_
8	are	_	_	VBP	_	_	_	_	_
9	amorphous	_	_	JJ	_	_	_	_	_
10	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	case	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	inulin	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	process	_	_	NN	_	_	_	_	_
10	variables	_	_	NNS	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	spray-drying	_	_	NN	_	_	_	_	_
13	such	_	_	JJ	_	_	_	_	_
14	as	_	_	IN	_	_	_	_	_
15	feed	_	_	NN	_	_	_	_	_
16	temperature	_	_	NN	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	inlet	_	_	NN	_	_	_	_	_
19	air	_	_	NN	_	_	_	_	_
20	temperature	_	_	NN	_	_	_	_	_
21	have	_	_	VBP	_	_	_	_	_
22	been	_	_	VBN	_	_	_	_	_
23	reported	_	_	VBN	_	_	_	_	_
24	to	_	_	TO	_	_	_	_	_
25	influence	_	_	VB	_	_	_	_	_
26	both	_	_	CC	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	morphology	_	_	NN	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	the	_	_	DT	_	_	_	_	_
31	degree	_	_	NN	_	_	_	_	_
32	of	_	_	IN	_	_	_	_	_
33	crystallinity	_	_	NN	_	_	_	_	_
34	of	_	_	IN	_	_	_	_	_
35	the	_	_	DT	_	_	_	_	_
36	microparticles	_	_	NNS	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	When	_	_	WRB	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	flavonoid-inulin	_	_	JJ	_	_	_	_	_
4	microparticles	_	_	NNS	_	_	_	_	_
5	are	_	_	VBP	_	_	_	_	_
6	incorporated	_	_	VBN	_	_	_	_	_
7	into	_	_	IN	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	lipid	_	_	NN	_	_	_	_	_
10	system	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	physical	_	_	JJ	_	_	_	_	_
14	state	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	these	_	_	DT	_	_	_	_	_
17	microparticles	_	_	NNS	_	_	_	_	_
18	(	_	_	-LRB-	_	_	_	_	_
19	semi-crystalline/amorphous	_	_	JJ	_	_	_	_	_
20	)	_	_	-RRB-	_	_	_	_	_
21	may	_	_	MD	_	_	_	_	_
22	influence	_	_	VB	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	oxidative	_	_	JJ	_	_	_	_	_
25	stability	_	_	NN	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	system	_	_	NN	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	but	_	_	CC	_	_	_	_	_
31	this	_	_	DT	_	_	_	_	_
32	still	_	_	RB	_	_	_	_	_
33	has	_	_	VBZ	_	_	_	_	_
34	not	_	_	RB	_	_	_	_	_
35	been	_	_	VBN	_	_	_	_	_
36	addressed	_	_	VBN	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	objective	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	this	_	_	DT	_	_	_	_	_
5	research	_	_	NN	_	_	_	_	_
6	was	_	_	VBD	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	design	_	_	VB	_	_	_	_	_
9	flavonoids	_	_	NNS	_	_	_	_	_
10	(	_	_	-LRB-	_	_	_	_	_
11	epicatechin	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	quercetin	_	_	NN	_	_	_	_	_
14	)	_	_	-RRB-	_	_	_	_	_
15	microparticles	_	_	NNS	_	_	_	_	_
16	with	_	_	IN	_	_	_	_	_
17	inulin	_	_	NN	_	_	_	_	_
18	as	_	_	IN	_	_	_	_	_
19	encapsulating	_	_	VBG	_	_	_	_	_
20	agent	_	_	NN	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	to	_	_	TO	_	_	_	_	_
23	evaluate	_	_	VB	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	influence	_	_	NN	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	physical	_	_	JJ	_	_	_	_	_
29	state	_	_	NN	_	_	_	_	_
30	of	_	_	IN	_	_	_	_	_
31	spray-dried	_	_	JJ	_	_	_	_	_
32	flavonoid	_	_	NN	_	_	_	_	_
33	microparticles	_	_	NNS	_	_	_	_	_
34	(	_	_	-LRB-	_	_	_	_	_
35	semi-crystalline/amorphous	_	_	JJ	_	_	_	_	_
36	)	_	_	-RRB-	_	_	_	_	_
37	on	_	_	IN	_	_	_	_	_
38	the	_	_	DT	_	_	_	_	_
39	oxidative	_	_	JJ	_	_	_	_	_
40	stability	_	_	NN	_	_	_	_	_
41	of	_	_	IN	_	_	_	_	_
42	lipid	_	_	NN	_	_	_	_	_
43	systems	_	_	NNS	_	_	_	_	_
44	.	_	_	.	_	_	_	_	_

